ABSTRACT
The discovery of antimicrobial drugs provided a great advance in medicine reducing significantly the mortality rates, revolutionizing the treatment of infectious diseases. Use of nanoparticles is one of the strategies to overcome resistance to antimicrobial drugs in patients with cystic fibrosis. Inorganic nanomaterials exhibit physical properties which demonstrate advantages in biological applications. The multi-walled carbon nanotubes, for example, have a low antimicrobial activity, although limited, this can be increased with the use of drugs or nanoparticles. Antifungal drugs are considerably fewer in number because of emergence of newer pathogenic fungi causing deep-seated mycosis. Clinically used major groups of antifungal agents are polyene antibiotics, azole derivatives, allylamines-thiocarbamates and morpholines. Nanotechnology and nanoscience are increasingly present in the media because they are attracting interest not only scientific but also industrial and financial. Nanotechnology is being used to produce biodegradable films derived from quinoa seeds. The use of these films is applied primarily on cover and food packaging, in order to maintain quality.
